Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site
Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 9
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Marine natural products
Anthony R. Carroll, Brent R. Copp, Rohan A. Davis, et al.
Natural Product Reports (2023) Vol. 40, Iss. 2, pp. 275-325
Closed Access | Times Cited: 189
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 107
Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 30
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site
Lun Tan, Chengyong Wu, Jifa Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3588-3620
Closed Access | Times Cited: 24
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
Laurence Lafanéchère
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Biosynthesis of Dolastatin 10 in Marine Cyanobacteria, a Prototype for Multiple Approved Cancer Drugs
Dimitris Kallifidas, Dipesh Dhakal, Man‐Yun Chen, et al.
Organic Letters (2024) Vol. 26, Iss. 7, pp. 1321-1325
Open Access | Times Cited: 7
Structure-based discovery and rational design of microtubule-targeting agents
Michel O. Steinmetz, A.E. Prota
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102845-102845
Open Access | Times Cited: 6
The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites
José M. Andreu, Sonia Huecas, Lidia Araújo‐Bazán, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1825-1825
Open Access | Times Cited: 23
Computational Approaches to the Rational Design of Tubulin-Targeting Agents
Helena Pérez‐Peña, Anne‐Catherine Abel, M. D. Shevelev, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 285-285
Open Access | Times Cited: 14
Globospiramine from Voacanga globosa Exerts Robust Cytotoxic and Antiproliferative Activities on Cancer Cells by Inducing Caspase-Dependent Apoptosis in A549 Cells and Inhibiting MAPK14 (p38α): In Vitro and Computational Investigations
Joe Anthony Manzano, Elian Angelo Abellanosa, Jose Paolo Aguilar, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 772-772
Open Access | Times Cited: 5
Microtubules destabilizing agents binding sites in tubulin
Daniel Alpízar-Pedraza, Ania de la Nuez Veulens, Enrique Colina Araújo, et al.
Journal of Molecular Structure (2022) Vol. 1259, pp. 132723-132723
Closed Access | Times Cited: 21
Design, synthesis, and bioevaluation of 1 h -pyrrolo[3,2- c ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Progress in the discovery and development of anticancer agents from marine cyanobacteria
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 4
Identification of a ligand-binding site on tubulin mediating the tubulin–RB3 interaction
Yong Li, Chufeng Zhang, Tang Dongmei, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Tubulin targeting agents and their implications in non-cancer disease management
Samridhi Lal, Timothy J. Snape
Drug Discovery Today (2025) Vol. 30, Iss. 4, pp. 104338-104338
Closed Access
Rational Design of a Novel Tubulin Inhibitor with a Unique Mechanism of Action
Tobias Mühlethaler, Lampros Milanos, Jose Antonio Ortega, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 25
Open Access | Times Cited: 17
Identification of therapeutic targets for chronic kidney disease through Mendelian randomization analysis of druggable genes
Raymond Liang, Jian Su, Xiangqi Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular Docking of Cryptoconcatones to α-Tubulin and Related Pironetin Analogues
Gérard Vergoten, Christian Bailly
Plants (2023) Vol. 12, Iss. 2, pp. 296-296
Open Access | Times Cited: 9
The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and Cancer
Daniela Trisciuoglio, Francesca Degrassi
Cancers (2021) Vol. 14, Iss. 1, pp. 6-6
Open Access | Times Cited: 18
Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function
María A. Oliva, Carlota Tosat‐Bitrián, Lucía Barrado-Gil, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3448-3448
Open Access | Times Cited: 14
Imidazo[4,5-b]pyridine derived tubulin polymerization inhibitors: Design, synthesis, biological activity in vitro and computational analysis
Ida Boček, Lucija Hok, Leentje Persoons, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 106032-106032
Closed Access | Times Cited: 14
Anti-Inflammatory Dysidazirine Carboxylic Acid from the Marine Cyanobacterium Caldora sp. Collected from the Reefs of Fort Lauderdale, Florida
Sarath P. Gunasekera, Sofia Kokkaliari, Ranjala Ratnayake, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1717-1717
Open Access | Times Cited: 13
Microtubule-Stabilizing 1,2,4-Triazolo[1,5-a]pyrimidines as Candidate Therapeutics for Neurodegenerative Disease: Matched Molecular Pair Analyses and Computational Studies Reveal New Structure–Activity Insights
Thibault Alle, Carmine Varricchio, Yuemang Yao, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 435-459
Open Access | Times Cited: 13
Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors
Jifa Zhang, Lun Tan, Chengyong Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115085-115085
Closed Access | Times Cited: 7
Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
Wei Liu, Youyou He, Zhongjie Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top